Evidence map›Paper›PMID 30280423›Full record

ArticleClinical and experimental dermatology2019

Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin.

J S Lehman, S Dasari, S S Damodaran, R A El-Azhary, L E Gibson, S K Hashmi, W J Hogan, S J Kenderian, M S Patnaik, M R Litzow and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Clinical and experimental dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

J S LehmanDepartment of Dermatology, Mayo Clinic, Rochester, MN, USA.
S DasariDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
S S DamodaranDepartment of Dermatology, Mayo Clinic, Rochester, MN, USA.
R A El-AzharyDepartment of Dermatology, Mayo Clinic, Rochester, MN, USA.
L E GibsonDepartment of Dermatology, Mayo Clinic, Rochester, MN, USA.
S K HashmiDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
W J HoganDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
S J KenderianDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
M S PatnaikDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
M R LitzowDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
H M LazarusAdult Hematologic Malignancies and Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
A MevesDepartment of Dermatology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USDepartment of Medical Sciences · BYUniversity Hospitals Case Medical Center · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
Precision Medicine by Targeting Cell Adhesion in MelanomaK08CA215105 · NCI · MAYO CLINIC ROCHESTER · PI MEVES, ALEXANDER · 2017 to 2021
$854k
Department of Dermatology at Mayo ClinicDermatology Foundation Dermatopathology Career Development AwardNCATS NIH HHS KL2 TR002379NCI NIH HHS K08 CA215105NCRR NIH HHS M01 RR000585
6 · The paper itself

Abstract

backgroundIn both acute graft-versus-host disease (GVHD) and lupus erythematosus (LE), the patient's own tissues are subjected to immunological assault via complex mechanisms influenced by interferon (IFN) and other cytokines. Although not typically confused clinically, these entities have overlapping histopathological findings in the skin.

aimTo assess whether GVHD can be differentiated from LE using molecular methods on skin specimens.

methodsWe developed a quantitative reverse transcription PCR assay based on previously identified tissue-based biomarkers of cutaneous GVHD, and compared gene expression in GVHD with that in LE.

resultsBoth entities showed robust expression of IFN-induced genes and of genes encoding proteins involved in antigen presentation, cell signalling and tissue repair. Levels of gene expression differed significantly in GVHD compared with LE, particularly those of IFN-induced genes such as MX1, OAS3, TAP1 and STAT3 (P < 0.01). Three logistic regression models could differentiate the two entities with a high degree of certainty (receiver operating characteristic area under the curve of 1.0).

conclusionThe study demonstrates the feasibility of distinguishing between microscopically similar inflammatory dermatoses using tissue-based molecular techniques.

Indexed as

Acute DiseaseAdultAgedAged, 80 and overCytokinesFemaleGene ExpressionGraft vs Host DiseaseHumansInterferonsLupus Erythematosus, SystemicMaleMiddle AgedReverse Transcriptase Polymerase Chain ReactionSkin DiseasesCytokinesInterferons

Identifiers

PMID30280423
PMCPMC6445793
OpenAlexW2894630001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.